Fidelity Management & Research Company
Biotech Investor · 5 portfolio companies
Portfolio
5
Combined Value
$4.9B
Focus Areas
12
Top Stage
Phase 3
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Beam Therapeutics | $2.5B |
| Intellia Therapeutics | $1.5B |
| Fulcrum Therapeutics | $450.9M |
| CAMP4 Therapeutics | $259.4M |
| Adagene | $171.1M |